Dysregulation of cyclin E can lead to uncontrolled cell proliferation and is often associated with cancer. Overexpression of cyclin E can bypass normal cell cycle checkpoints, leading to genomic instability and tumorigenesis. Conversely, insufficient cyclin E activity can result in cell cycle arrest and impaired cell proliferation.
